IDH2 and CD28 mutations were seen in only AITL (25%, 4% respectively), and not in PTCL‐TFH, with mutation in the remaining genes being at low frequencies in both groups. This evidence concerns the gene CD28 and angioimmunoblastic T-cell lymphoma.